Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Usha D. Hemraz has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tuneable structural and environmental factors for stability of rosette nanotubes

    by Usha D. Hemraz, Takeshi Yamazaki, Rachel L. Beingessner, Jae-Young Cho, Hicham Fenniri

    Rosette nanotubes (RNTs) are biocompatible tubular architectures self-assembled under physiological conditions from a self-complementary DNA base hybrid molecule which features the hydrogen-bonding arrays of both guanine and cytosine (G∧C motif).

  • Open Access

    Thermo-responsive polysulfobetaine beads crosslinked with biodegradable alginates for controlled release of agricultural pesticide

    by Brandon Andrade-Gagnon, Chloe Olszewski, Kamaljeet Kaur Bawa, Usha D. Hemraz, Jung Kwon Oh

    The rise in global food demand and the loss in crop production by pests highlight the need for efficient pesticide delivery systems. Stimuli-responsive degradation with thermoresponsive polymers is a promising platform that offers the controlled release of pesticides. Here, we report the development of millimeter-sized thermoresponsive beads (m-beads) composed of a zwitterionic polysulfobetaine exhibiting upper critical solution temperature (UCST) behavior, crosslinked with biodegradable alginate via supramolecular ionic interactions with calcium ions in water. The fabricated m-beads are capable of encapsulating fluorescein and glufosinate ammonium pesticide with encapsulation efficiency greater than 99%. Promisingly, they exhibit enhanced release with an increasing amount of alginate in m-beads as well as at a temperature above the UCST. This work highlights the potential of UCST-type polysulfobetaine-based m-beads as a smart delivery platform, offering environmentally-triggered release of pesticides.


  • Open Access

    Immunogenicity of Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Versus Non-Adjuvanted SARS-CoV-2 Spike Booster Vaccines in Young and Aged Balb/c Mice

    by Felicity C. Stark, Bassel Akache, Tyler M. Renner, Gerard Agbayani, Lise Deschatelets, Renu Dudani, Blair A. Harrison, Usha D. Hemraz, Sophie Régnier, Matthew Stuible, et al.

    Background/Objectives: The rise of immune escape variants of the SARS-CoV-2 virus has prompted the development of vaccines based on the variant’s spike antigen sequence. Since variant-specific SARS-CoV-2 vaccines are mostly administered as boosters to individuals previously vaccinated with reference (Ref.) strain-based vaccines, a better understanding of their immunogenicity in this context is essential. Protein subunit vaccines have a well-established track record of safety. Herein, we assessed the ability of variant-specific protein subunit vaccine formulations to boost pre-existing Ref. strain-specific immune responses compared to boosting with a Ref. strain-specific formulation in young and aged female Balb/c mice. Methods: Following a priming vaccination series with Ref. spike protein adjuvanted with sulfated lactosyl archaeol (SLA) archaeosomes on days 0 and 21, immune responses were evaluated in young and aged female Balb/c mice. On day 91, mice received a third immunization with Ref., Beta, or Delta spike protein formulations, with or without SLA archaeosomes. Antibody titers, neutralization activity, and cellular immune responses were measured to assess the impact of the booster formulation. Results: Aged mice exhibited lower antibody titers throughout the study and a decline over time compared to young mice. After a third immunization, responses were boosted by all vaccine formulations (Ref., Beta, or Delta), with or without adjuvant. However, variant-specific antigen formulations did not overcome immune imprinting from the priming series or increase neutralization activity against the corresponding SARS-CoV-2 variants in either age group. Conclusions: Variant-specific protein subunit vaccines enhanced immune responses but did not overcome immune imprinting induced by the Ref. strain’s priming. The inclusion of SLA archaeosomes improved cellular immunity, supporting their potential role in optimizing booster vaccine performance, particularly in aged populations.


  • Open Access

    Self-assembled rosette nanotubes from tetra guanine-cytosine modules

    by Usha D. Hemraz, Takeshi Yamazaki, Mounir El-Bakkari, Jae-Young Cho, Hicham Fenniri

    Self-assembly of small molecules into supramolecular architectures is a sustainable alternative to new advanced material design.


  • Open Access

    Synthesis of sulfated lactosyl glycosides for evaluation in vaccine adjuvant formulations

    by Tarasha Sharma, Sophie Régnier, Lise Deschatelets, Felicity C. Stark, Vinicio Vasquez, Camilo F. Martinez-Farina, Renu Dudani, Blair A. Harrison, Bassel Akache, Yimei Jia, et al.

    Adjuvants are essential components of vaccines as they enable protection against multiple pathogens by enhancing the duration, magnitude and or quality of immune responses. SLA Archaeosomes, a type of liposome composed of sulfated lactosyl archaeol (SLA) glycolipids, are highly stable vaccine adjuvants that have been shown to induce strong immune responses in preclinical models of infectious disease and cancer. To better understand the mechanism of activity behind SLA archaeosomes strong immunogenic properties, we studied the effect of structural change on vaccine adjuvanticity. Herein, we report the synthesis of three new sulfated lactosyl glycosides (SLGs) by replacing the archaeol moiety with various side-chains. These derivatives were characterized using nuclear magnetic resonance, mass spectrometry, and thin layer chromatography for identity and purity assessment. The SLGs were co-assembled in the presence of DMPC and cholesterol to produce lipid vesicles. The abilities of the SLG-based liposomes to act as vaccine adjuvants were compared to SLA archaeosomes in an in vivo murine vaccine model.

  • Open Access

    Fabrication of thermo-responsive multicore microcapsules using a facile extrusion process

    by Jean-Danick Lavertu, Kamaljeet Kaur Bawa, Sabahudin Hrapovic, Dong Fu, Jung Kwon Oh, Usha D. Hemraz

    A process employing extrusion was used to produce multicore microcapsules composed of multiple beads.


  • Open Access

    Encapsulation of Plant Growth-Promoting Bacteria in Poly(itaconic acid) Microspheres by Spray Drying

    by Vitaliy Kapishon, Marie-Josée Lorrain, Alfred C. W. Leung, Anne-Marie Gélinas, Meiqun Wu, Manon Sarrazin, Sabahudin Hrapovic, Antoine Pagé, Fanny Monteil-Rivera, Usha D. Hemraz


  • Open Access

    Delivery of siRNA using cationic rosette nanotubes for gene silencing

    by Uyen Ho, Mounir El-Bakkari, Aws Alshamsan, Jae-Young Cho, Takeshi Yamazaki, Usha D. Hemraz, Hicham Fenniri

    The quest for new therapeutic treatments for hereditary diseases has led to many advances in RNA interference (RNAi) and gene silencing. While this technique has the potential to address many problems, the key to its continued use is the development of effective delivery strategies that would reduce cellular toxicity and increase silencing efficiency. Rosette nanotubes (RNTs) are biomimetic supramolecular nanostructures formed through the self-assembly of hybrid guanine–cytosine (G∧C) DNA bases. Here, we used bioactive RNTs for siRNA delivery and gene silencing. Fifteen lysine-functionalized twin-G∧C motifs (KnT, n = 1 to 15) were synthesized using solid phase peptide synthesis to produce building blocks that self-assembled to produce cationic RNTs under physiological conditions. The intracellular uptake of siRNA delivered by the oligo-L-lysine RNTs was examined and it was found that the complexation of siRNA was affected by the cationic charges from the lysine residues and the length of RNTs formed, with the higher charged KnT RNTs delivering siRNA to the cells at a faster rate. In addition, by protecting siRNA from serum degradation, KnT RNTs were shown to deliver their cargo to the cells effectively via the endocytic pathway. A reduction in the expression (∼70%) of the target stat3 protein was observed during gene expression analysis in HCT116 and A549 cell lines.


  • Open Access

    Sulfated Lactosyl Archaeol Archaeosome-Adjuvanted Vaccine Formulations Targeting Rabbit Hemorrhagic Disease Virus Are Immunogenic and Efficacious

    by Bassel Akache, Andrew J. Read, Renu Dudani, Blair A. Harrison, Dean Williams, Lise Deschatelets, Yimei Jia, Vandana Chandan, Felicity C. Stark, Gerard Agbayani, et al.

    Vaccines play an important role in maintaining human and animal health worldwide. There is continued demand for effective and safe adjuvants capable of enhancing antigen-specific responses to a target pathogen. Rabbit hemorrhagic disease virus (RHDV) is a highly contagious calicivirus that often induces high mortality rates in rabbits. Herein, we evaluated the activity of an experimental sulfated lactosyl archaeol (SLA) archaeosome adjuvant when incorporated in subunit vaccine formulations targeting RHDV. The subunit antigens consisted of RHDV–CRM197 peptide conjugates or recombinant RHDV2 VP60. SLA was able to enhance antigen-specific antibody titers and cellular responses in mice and rabbits. Three weeks following immunization, antigen-specific antibody levels in rabbits vaccinated with RHDV2 VP60 + SLA were significantly higher than those immunized with antigen alone, with geomean titers of 7393 vs. 117. In addition, the SLA-adjuvanted VP60-based formulations were highly efficacious in a rabbit RHDV2 challenge model with up to 87.5% animals surviving the viral challenge. These findings demonstrate the potential utility of SLA adjuvants in veterinary applications and highlight its activity in different types of mammalian species.


  • Design of chitosan nanocrystals decorated with amino acids and peptides

    by Sabahudin Hrapovic, Camilo F. Martinez-Farina, Jessie Sui, Jean-Danick Lavertu, Usha D. Hemraz